Detalhe da pesquisa
1.
Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response.
Cancer Immunol Immunother
; 62(6): 999-1010, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591980
2.
Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.
J Immunol Methods
; 398-399: 51-9, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24055592